Studies find faults in FDA approval process for cardiac devices

12/29/2009 | Wall Street Journal, The ·

The FDA approves some heart devices based on a single clinical study and other inadequate standards, according to two studies published separately in two medical journals. Dr. Jeffrey Shuren, acting director of the FDA's Center for Devices and Radiological Health, said the agency has started developing tougher standards and has called on firms to collaborate with the FDA in creating specific objectives for their clinical trials.

View Full Article in:

Wall Street Journal, The ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA